RxDoctor Payments Data

Thomas Simpson, MD

Otolaryngology/Facial Plastic Surgery · Iowa City, IANPI 1285672428

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $881, 3.5 times the $252 reported in 2019.

$2,142in general payments, 2019–2025

Across 85 payments — averaging $25.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$291
  • Sanofi$252
  • Medtronic$228
  • Jazz Pharmaceuticals Inc.$217
  • Organogenesis Inc.$201
  • Smith+Nephew$172
  • plus $782 from 18 others

What the payments were for

  • Food & beverage$2,142100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Iowato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$297,749
Medicare patients
935
Services billed
4,875

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine772$5,280
Ipratropium Bromide190$5,142
Fluticasone Propionate168$2,027
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth12$1,485
Pantoprazole Sodium205$1,465
Flunisolide33$1,203
Omeprazole51$660
Cefdinir19$629
Prednisolone Acetate13$564
Ropinirole Hcl48$547
Ofloxacin30$381
Montelukast Sodium54$295
Sulfacetamide-PrednisoloneSulfacetamide/Prednisolone Sp22$275
Gabapentin19$244
Pramipexole DihydrochloridePramipexole Di-Hcl18$233

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Iowa City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →